WO2021140507A2 - Systèmes de stimulation de valvule aortique prothétique - Google Patents

Systèmes de stimulation de valvule aortique prothétique Download PDF

Info

Publication number
WO2021140507A2
WO2021140507A2 PCT/IL2021/050016 IL2021050016W WO2021140507A2 WO 2021140507 A2 WO2021140507 A2 WO 2021140507A2 IL 2021050016 W IL2021050016 W IL 2021050016W WO 2021140507 A2 WO2021140507 A2 WO 2021140507A2
Authority
WO
WIPO (PCT)
Prior art keywords
prosthetic
valve
coil
energy
cathode
Prior art date
Application number
PCT/IL2021/050016
Other languages
English (en)
Other versions
WO2021140507A3 (fr
WO2021140507A9 (fr
Inventor
Yossi Gross
Original Assignee
E-Valve Systems Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/734,798 external-priority patent/US10835750B2/en
Application filed by E-Valve Systems Ltd. filed Critical E-Valve Systems Ltd.
Priority to CN202180018317.6A priority Critical patent/CN115297806A/zh
Priority to US17/328,588 priority patent/US11291844B2/en
Publication of WO2021140507A2 publication Critical patent/WO2021140507A2/fr
Publication of WO2021140507A3 publication Critical patent/WO2021140507A3/fr
Publication of WO2021140507A9 publication Critical patent/WO2021140507A9/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/3629—Heart stimulators in combination with non-electric therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418—Scaffolds therefor, e.g. support stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056—Transvascular endocardial electrode systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/378—Electrical supply
    • A61N1/3787—Electrical supply from an external energy source
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056—Transvascular endocardial electrode systems
    • A61N1/057—Anchoring means; Means for fixing the head inside the heart
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators
    • A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
    • A61N1/37223—Circuits for electromagnetic coupling
    • A61N1/37229—Shape or location of the implanted or external antenna
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/375—Constructional arrangements, e.g. casings
    • A61N1/37512—Pacemakers

Definitions

  • the present invention relates generally to surgical implants and systems, and specifically to prosthetic aortic valves and systems.
  • Aortic heart valve replacement may be necessary to treat valve regurgitation or stenotic calcification of the leaflets.
  • a prosthetic aortic valve is compressed for delivery in a catheter and advanced through the descending aorta to the heart, where the prosthetic valve is deployed in the aortic valve annulus.
  • New-onset cardiac conduction disturbances are common after transcatheter aortic valve implantation (TAVI).
  • TAVI transcatheter aortic valve implantation
  • the most common complication is left bundle branch block (LBBB).
  • US Patent 7,914,569 to Nguyen et al. which is incorporated herein by reference, describes a heart valve prosthesis having a self-expanding multi-level frame that supports a valve body comprising a skirt and plurality of coapting leaflets.
  • the frame transitions between a contracted delivery configuration that enables percutaneous transluminal delivery, and an expanded deployed configuration having an asymmetric hourglass shape.
  • the valve body skirt and leaflets are constructed so that the center of coaptation may be selected to reduce horizontal forces applied to the commissures of the valve, and to efficiently distribute and transmit forces along the leaflets and to the frame.
  • the valve body may be used as a surgically implantable replacement valve prosthesis.
  • a prosthetic aortic valve which comprises a plurality of prosthetic leaflets, a frame, and one or more electrodes coupled to the frame.
  • the frame is shaped so as to define an upstream inflow portion; a downstream outflow portion; and a constriction portion, which is axially between the upstream inflow portion and the downstream outflow portion.
  • the prosthetic leaflets are coupled to the constriction portion.
  • the prosthetic aortic valve further comprises a prosthetic-valve coil, which is in non-wireless electrical communication with the one or more electrodes, and which is coupled to the frame no more than 1 mm upstream of the ring-shaped longitudinal border, such as axially along the downstream outflow portion.
  • a valve prosthesis system which includes a prosthetic aortic valve and a non-implantable unit.
  • the prosthetic aortic valve which includes a plurality of prosthetic leaflets; a frame; a cathode and an anode, which are mechanically coupled to the frame; and a prosthetic-valve coil, which is in non-wireless electrical communication with the cathode and the anode.
  • the non-implantable unit includes an energy-transmission coil; and non-implantable control circuitry, which is configured to drive the cathode and the anode to apply a pacing signal and to set parameters of the pacing signal, by wirelessly transferring energy from the energy-transmission coil to the prosthetic-valve coil by inductive coupling.
  • a valve prosthesis system comprising:
  • a prosthetic aortic valve which comprises:
  • a prosthetic-valve coil which is in non-wireless electrical communication with the cathode and the anode; and (ii) a non-implantable unit, which comprises:
  • an energy-transmission coil (a) an energy-transmission coil; and (b) non-implantable control circuitry, which is configured to drive the cathode and the anode to apply a pacing signal and to set parameters of the pacing signal, by wirelessly transferring energy from the energy-transmission coil to the prosthetic-valve coil by inductive coupling.
  • Inventive concept 2 The valve prosthesis system according to Inventive concept 1, wherein the prosthetic aortic valve comprises one or more elongate insulated electrical conductors, which directly couple the prosthetic-valve coil in the non-wireless electrical communication with the cathode and the anode.
  • Inventive concept 3 The valve prosthesis system according to Inventive concept 1, wherein respective ends of the prosthetic-valve coil are in the non-wireless electrical communication with the cathode and the anode.
  • Inventive concept 4 The valve prosthesis system according to Inventive concept 1, wherein respective non-electrically-insulated end portions of the prosthetic-valve coil define the cathode and the anode.
  • Inventive concept 5 The valve prosthesis system according to Inventive concept 1, wherein the non-implantable control circuitry is configured to set an amplitude of the pacing signal by modulating an amplitude of the energy wirelessly transferred from the energy-transmission coil to the prosthetic-valve coil.
  • Inventive concept 6 The valve prosthesis system according to Inventive concept 1, wherein the pacing signal includes pulses, and wherein the non-implantable control circuitry is configured to drive the cathode and the anode to (a) begin application of each pulse of the pacing signal by beginning wirelessly transferring energy from the energy- transmission coil to the prosthetic-valve coil, and (b) conclude the application of each pulse of the pacing signal by ceasing wirelessly transferring energy from the energy- transmission coil to the prosthetic-valve coil.
  • Inventive concept 7 The valve prosthesis system according to Inventive concept 1, wherein the frame is shaped so as to define: (1) an upstream inflow portion, (2) a downstream outflow portion, and (3) a constriction portion, which is axially between the upstream inflow portion and the downstream outflow portion, wherein the prosthetic leaflets are coupled to the constriction portion, and wherein the cathode is mechanically coupled to the upstream inflow portion of the frame.
  • Inventive concept 8 The valve prosthesis system according to Inventive concept 7, wherein the prosthetic-valve coil is disposed axially along the downstream outflow portion of the frame.
  • Inventive concept 9 The valve prosthesis system according to Inventive concept 1, wherein the cathode and the anode are disposed on the frame such that there is at least 15 mm between the cathode and the anode, when the prosthetic aortic valve is in an expanded fully-deployed configuration, the 15 mm measured along a central longitudinal axis of the frame when in the expanded fully-deployed configuration.
  • Inventive concept 10 The valve prosthesis system according to any one of Inventive concepts 1-9, wherein the non-implantable unit is an external unit, which is configured to be disposed outside a body of a subject in which the prosthetic aortic valve is disposed.
  • Inventive concept 11 The valve prosthesis system according to any one of Inventive concepts 1-9, wherein the non-implantable unit is a delivery system, which further comprises a delivery tube, and one or more wires, which pass along the delivery tube, wherein the energy-transmission coil is a delivery-system coil, wherein the non-implantable control circuitry is delivery-system control circuitry, which is in electrical communication with the delivery-system coil via the one or more wires, and wherein the delivery-system coil is coupled to the delivery tube at a distal site of the delivery tube.
  • the non-implantable unit is a delivery system, which further comprises a delivery tube, and one or more wires, which pass along the delivery tube
  • the energy-transmission coil is a delivery-system coil
  • the non-implantable control circuitry is delivery-system control circuitry, which is in electrical communication with the delivery-system coil via the one or more wires, and wherein the delivery-system coil is coupled to the delivery tube at a distal site of the delivery tube.
  • Inventive concept 12 The valve prosthesis system according to Inventive concept 11, wherein the delivery-system control circuitry is configured to drive the cathode and the anode to apply rapid ventricular pacing, by wirelessly transferring the energy from the energy-transmission coil to the prosthetic-valve coil by inductive coupling.
  • Inventive concept 13 The valve prosthesis system according to Inventive concept 11, wherein the prosthetic aortic valve is (i) removably disposable in the delivery tube in a compressed delivery configuration and (ii) configured to assume: (A) a partially-expanded partially-deployed configuration upon being partially released from a distal end of the delivery tube such that (1) at least the cathode is positioned outside the delivery tube, and (2) the prosthetic-valve coil is compressed within the delivery tube, and
  • the valve prosthesis system according to Inventive concept 13 further comprising an external unit, which is configured to be disposed outside a body of a subject in which the prosthetic aortic valve is disposed, and which comprises: an external-unit coil; and external-unit control circuitry, which is configured to drive the external-unit coil to drive the cathode and the anode to apply the pacing signal and to set the parameters of the pacing signal, by wirelessly transferring energy, by inductive coupling, to the prosthetic- valve coil when the prosthetic aortic valve is in the expanded fully-deployed configuration.
  • an external unit which is configured to be disposed outside a body of a subject in which the prosthetic aortic valve is disposed, and which comprises: an external-unit coil; and external-unit control circuitry, which is configured to drive the external-unit coil to drive the cathode and the anode to apply the pacing signal and to set the parameters of the pacing signal, by wirelessly transferring energy, by inductive coupling, to
  • a method comprising: deploying, via vasculature of a patient, a prosthetic aortic valve of a valve prosthesis system in an aortic valve annulus, the prosthetic aortic valve including (a) a plurality of prosthetic leaflets, (b) a frame, (c) a cathode and an anode, which are mechanically coupled to the frame, and (d) a prosthetic-valve coil, which is in non wireless electrical communication with the cathode and the anode; and activating non-implantable control circuitry of a non-implantable unit of the valve prosthesis system to drive the cathode and the anode to apply a pacing signal and to set parameters of the pacing signal, by wirelessly transferring energy from an energy- transmission coil of the non-implantable unit to the prosthetic-valve coil by inductive coupling.
  • Inventive concept 15 The method according to Inventive concept 15, wherein the non-implantable unit is a delivery system of the valve prosthesis system, and the energy-transmission coil is a delivery-system coil that is coupled to a delivery tube of the delivery system at a distal site of the delivery tube, wherein the non-implantable control circuitry is delivery-system control circuitry, which is in electrical communication with the delivery-system coil via one or more wires that pass along the delivery tube, wherein deploying the prosthetic aortic valve comprises: advancing the delivery tube through the vasculature until a distal end of the delivery tube is disposed in an ascending aorta of the patient, while the prosthetic aortic valve is removably disposed in the delivery tube in a compressed delivery configuration; and partially releasing the prosthetic aortic valve from the distal end of the delivery tube such that the prosthetic aortic valve assumes a partially-expanded partially-deployed configuration, in which (a) at least the cathode
  • Inventive concept 16 The method according to Inventive concept 15, wherein activating the delivery-system control circuitry comprises activating the delivery-system control circuitry to drive the cathode and the anode to apply rapid ventricular pacing, by wirelessly transferring the energy from the energy-transmission coil to the prosthetic- valve coil by inductive coupling at least when the prosthetic aortic valve is in the partially-deployed configuration.
  • activating the delivery-system control circuitry comprises activating the delivery-system control circuitry to drive the cathode and the anode to apply rapid ventricular pacing, by wirelessly transferring the energy from the energy-transmission coil to the prosthetic- valve coil by inductive coupling at least when the prosthetic aortic valve is in the partially-deployed configuration.
  • the method according to Inventive concept 15, further comprising, after fully releasing the prosthetic aortic valve from the distal end of the delivery tube, activating external-unit control circuitry of an external unit to drive an external-unit coil of the external unit to drive the cathode and the anode to apply the pacing signal and to set the parameters of the pacing signal, by wirelessly transferring energy, by inductive coupling, to the prosthetic-valve coil when the prosthetic aortic valve is in the expanded fully-deployed configuration, wherein the external unit is disposed outside a body of a subject in which the prosthetic aortic valve is disposed.
  • Inventive concept 18 The method according to Inventive concept 15, wherein the delivery-system control circuitry is configured to cease driving the delivery-system coil to drive the cathode and the anode when the prosthetic aortic valve assumes the expanded fully-deployed configuration upon being fully released from the distal end of the delivery tube.
  • Inventive concept 19 The method according to Inventive concept 15, wherein partially releasing the prosthetic aortic valve from the distal end of the delivery tube comprises positioning the cathode adjacent to cardiac tissue near the bundle of His.
  • Inventive concept 20 The method according to Inventive concept 19, wherein positioning the cathode adjacent to the cardiac tissue near the bundle of His comprises rotating the prosthetic aortic valve if necessary during deployment such that the cathode is disposed against the cardiac tissue near the bundle of His.
  • FIGs. 1A and IB are schematic illustrations of a prosthetic aortic valve, in accordance with an application of the present invention
  • Fig. 2 is a schematic illustration of components of the prosthetic aortic valve of Figs. 1A-B before complete assembly, in accordance with an application of the present invention
  • FIG. 3 is a schematic illustration of another prosthetic aortic valve, in accordance with an application of the present invention
  • Figs. 4A-C are schematic illustrations of a valve prosthesis system and a method of using the system, in accordance with respective applications of the present invention.
  • Fig. 5 is a schematic illustration of an electronic implant, in accordance with an application of the present invention.
  • Figs. 1A and IB are schematic illustrations of a prosthetic aortic valve 20, in accordance with an application of the present invention.
  • Prosthetic aortic valve 20 is shown in Figs. 1A-B in an expanded configuration, which is similar to the expanded fully- deployed configuration described hereinbelow with reference to Fig. 4C, except that in Figs. 1A-B expansion of prosthetic aortic valve 20 is not limited by anatomy of a patient.
  • Fig. IB is a view of prosthetic aortic valve 20 from a downstream outflow end 52, as described hereinbelow.
  • Prosthetic aortic valve 20 comprises: a frame 30;
  • a prosthetic-valve coil 36 coupled to frame 30 and in non-wireless electrical communication with the one or more electrodes 34, optionally by one or more elongate insulated electrical conductors 38, e.g., wires.
  • Frame 30 typically comprises a stent or other structure, which is typically self expanding, and may be formed by laser cutting or etching a metal alloy tube comprising, for example, stainless steel or a shape memory material such as Nitinol.
  • a metal alloy tube comprising, for example, stainless steel or a shape memory material such as Nitinol.
  • one or more of electrodes 34 are coupled to frame 30 using techniques described in US Patent 9,526,637 to Dagan et al. and/or US 2016/0278951 to Dagan et al., both of which are incorporated herein by reference.
  • prosthetic- valve coil 36 comprises gold wire, in order to provide low resistance.
  • prosthetic aortic valve 20 further comprises prosthetic- aortic-valve control circuitry 40, which is coupled to frame 30 and which is in non wireless electrical communication with the one or more electrodes 34.
  • prosthetic-valve coil 36 is in non-wireless electrical communication with prosthetic-aortic-valve control circuitry 40, such that prosthetic-valve coil 36 is in non wireless electrical communication with the one or more electrodes 34 via prosthetic- aortic-valve control circuitry 40.
  • One or more of the one or more electrodes 34 may be directly attached in non-wireless electrical communication to prosthetic-aortic-valve control circuitry 40, and/or may be attached in non-wireless electrical communication to prosthetic-aortic-valve control circuitry 40 by the one or more elongate insulated electrical conductors 38.
  • prosthetic-aortic-valve control circuitry 40 is flexible, and has a thin, linear packaging, and may implement techniques described hereinbelow with reference to Fig. 5.
  • the thinness of control circuitry 40 allows it to be compressed in a delivery tube during deployment of prosthetic aortic valve 20, without the need to increase the diameter of the delivery tube.
  • the flexibility of control circuitry 40 prevents damage to the control circuitry when it is crimped when compressed into the delivery tube.
  • frame 30 is shaped so as to define an upstream inflow portion 42, a downstream outflow portion 44, and a constriction portion 46, which is axially between upstream inflow portion 42 and downstream outflow portion 44.
  • Prosthetic leaflets 32 are coupled to constriction portion 46 such that free edges 48 of prosthetic leaflets 32 face toward downstream outflow portion 44 when prosthetic aortic valve 20 is in the expanded fully-deployed configuration described hereinbelow with reference to Fig. 4C.
  • Prosthetic leaflets 32 are not coupled to downstream outflow portion 44; therefore, a ring-shaped longitudinal border 58 between downstream outflow portion 44 and constriction portion 46 is defined by a downstream-most point of frame 30 to which prosthetic leaflets 32 are coupled (for example, prosthetic leaflets 32 may be coupled to the downstream-most point of frame 30 at commissures 60, described immediately hereinbelow). (Ring-shaped longitudinal border 58 is at the same longitudinal location around frame 30.)
  • prosthetic aortic valve 20 further comprises a skirt 49 coupled to upstream inflow portion 42 of frame 30, and prosthetic leaflets 32 are attached along their bases to skirt 49, for example, using sutures or a suitable biocompatible adhesive.
  • Adjoining pairs of leaflets are attached to one another at their lateral ends to form commissures 60, with free edges 48 of the prosthetic leaflets forming coaptation edges that meet one another.
  • Skirt 49 and prosthetic leaflets 32 typically comprise a sheet of animal pericardial tissue, such as porcine pericardial tissue, or synthetic or polymeric material.
  • prosthetic-valve coil 36 is disposed no more than 1 mm upstream of ring-shaped longitudinal border 58 between downstream outflow portion 44 and constriction portion 46, typically axially along downstream outflow portion 44.
  • Such placement allows prosthetic aortic valve 20 to be crimped (compressed) into a delivery tube during deployment of prosthetic aortic valve 20, without requiring a larger-diameter delivery tube to accommodate prosthetic-valve coil 36.
  • downstream outflow portion 44 does not include material of prosthetic leaflets 32, and thus can accommodate prosthetic- valve coil 36 without causing downstream outflow portion 44 to have a greater compressed diameter than the other axial portions of prosthetic aortic valve 20.
  • prosthetic-valve coil 36 is not disposed axially along constriction portion 46 and is not disposed axially along upstream inflow portion 42.
  • placement of prosthetic-valve coil 36 axially along downstream outflow portion 44 improves transmission efficiency because downstream outflow portion 44 typically has a greater diameter than each of constriction portion 46 and upstream inflow portion 42.
  • constriction portion 46 typically has a lesser diameter than each of upstream inflow portion 42 and downstream outflow portion 44.
  • the one or more electrodes 34 is coupled to upstream inflow portion 42 of frame 30, such as exactly one of the one or more electrodes 34.
  • the one or more electrodes 34 comprise a cathode 54 that is coupled to upstream inflow portion 42 of frame 30, and prosthetic-aortic-valve control circuitry 40 is configured to drive cathode 54 to apply a cathodic current.
  • cathode 54 has a lateral dimension a (alpha), measured in degrees around frame 30 with respect to a central longitudinal axis 55 of frame 30, of between 10 and 40 degrees, e.g., between 20 and 40 degrees, such as 30 degrees, in order to accommodate rotational misplacement of frame 30 with respect to the bundle of His.
  • prosthetic aortic valve 20 is deployed using imaging, such as fluoroscopy, and is rotated if necessary during the deployment such that cathode 54 is disposed against tissue of the annulus that is near the bundle of His.
  • prosthetic aortic valve 20 comprises a plurality of cathodes 54 (e.g., two or three, or more), which are disposed at a respective plurality of angular locations around frame 30 (e.g., 10-15 degrees apart).
  • cathode 54 After implantation of prosthetic aortic valve 20, the cathode 54 that is has the most accurate angular location is activated to apply a pacing signal and/or sense, either by prosthetic - aortic-valve control circuitry 40 or external control circuitry, such as external-unit control circuitry 104, described hereinbelow with reference to Fig. 4C.
  • cathode 54 has an axial length of at least 10 mm, in order to accommodate axial misplacement of frame 30 with respect to the annulus of the natural aortic valve, and thus with respect to the bundle of His.
  • an "axial length" is a length of a structure measured along central longitudinal axis 55.
  • cathode 54 has a thickness of between 75 and 125 microns, e.g., about 100 microns, and/or a surface area of at least 2.5 mm2, in order to provide adequate stimulation.
  • cathode 54 comprises titanium nitride (TiN).
  • skirt 49 is coupled to an external surface of upstream inflow portion 42 of frame 30, and cathode 54 is disposed on an external surface of skirt 49.
  • the "central longitudinal axis" 55 of frame 30 is the set of all centroids of transverse cross-sectional sections of frame 30 along frame 30. Thus the cross-sectional sections are locally perpendicular to the central longitudinal axis, which runs along frame 30. (For applications in which frame 30 is circular in cross-section, the centroids correspond with the centers of the circular cross-sectional sections.)
  • prosthetic aortic valve 20 when prosthetic aortic valve 20 is in the expanded fully- deployed configuration described hereinbelow with reference to Fig. 4C:
  • frame 30 has an inflow end 50 at upstream inflow portion 42 and downstream outflow end 52 at downstream outflow portion 44, and an axial length, measured between inflow end 50 and downstream outflow end 52, and
  • the one or more electrodes 34 is coupled to upstream inflow portion 42 within a distance from inflow end 50, the distance equal to 10% of the axial length of frame 30 (the distance is measured (a) along central longitudinal axis 55 of frame 30 when in the expanded fully- deployed configuration, and (b) between inflow end 50 and an upstream-most point of the at least one electrode).
  • prosthetic-aortic-valve control circuitry 40 is coupled to frame 30 such that upstream-most point 56 of prosthetic-aortic-valve control circuitry 40 is disposed axially along constriction portion 46 and/or downstream outflow portion 44 of frame 30.
  • prosthetic-aortic-valve control circuitry 40 is coupled to frame 30 inside frame 30, which may prevent friction between prosthetic-aortic-valve control circuitry 40 and delivery tube 72 during deployment of prosthetic aortic valve 20, described hereinbelow with reference to Figs. 4A-C.
  • upstream-most point 56 is disposed no more upstream than 1 mm upstream of ring-shaped longitudinal border 58, such as described above, there is generally enough space inside frame 30 to accommodate prosthetic-aortic-valve control circuitry 40.
  • prosthetic leaflets 32 are coupled to frame 30 at at least first and second commissures 60A and 60B of prosthetic aortic valve 20 that are located at respective first and second angular locations 62A and 62B around frame 30.
  • the first and second angular locations 62A and 62B are separated by a first angular offset b (beta) around frame 30 when prosthetic aortic valve 20 is in the expanded fully-deployed configuration described hereinbelow with reference to Fig. 4C.
  • Prosthetic-aortic-valve control circuitry 40 is coupled to frame 30 at a third angular location 62C around frame 30 that is separated from first angular location 62A by a second angular offset d (delta) that equals between 40% and 60% (e.g., 50%) of the first angular offset b (beta) when prosthetic aortic valve 20 is in the expanded fully -deployed configuration described hereinbelow with reference to Fig. 4C.
  • the frame is more flexible than at the more rigid commissures.
  • an "angular location” is a location on frame 30 at a particular location around central longitudinal axis 55, i.e., at a particular "o'clock” with respect to central longitudinal axis 55. (It is noted that a third commissure 60C is shown in Fig. 1A on the far side of the frame, i.e., 180 degrees from circuitry 40.)
  • FIG. 2 is a schematic illustration of components of prosthetic aortic valve 20 before complete assembly, in accordance with an application of the present invention.
  • the components comprise a valve component 64 and an electronics component 66.
  • Valve component 64 typically consists of a heart valve prosthesis known in the art, which comprises at least frame 30 and prosthetic leaflets 32.
  • the known heart valve prosthesis may comprise a CoreValveTM EvolutTM R prothesis (Medtronic, Inc., Minneapolis, MN, USA), a CoreValveTM EvolutTM PRO prosthesis (Medtronic, Inc.), a LOTUS EdgeTM Aortic Valve (Boston Scientific Corporation, Marlborough, MA, USA), or an ACURATE neoTM Aortic Valve (Boston Scientific Corporation).
  • Electronics component 66 comprises at least the one or more electrodes 34 and prosthetic-valve coil 36, and optionally prosthetic-aortic-valve control circuitry 40.
  • electronics component 66 is inserted into valve component 64.
  • a first portion of electronics component 66 such as prosthetic-valve coil 36, prosthetic-aortic-valve control circuitry 40, and one of the one or more electrodes 34, is coupled to an inner surface of frame 30, and a second portion of electronics component 66, such as cathode 54, is coupled to an external surface of frame 30.
  • one 38A of one or more elongate insulated electrical conductors 38 may electrically couple cathode 54 to prosthetic-aortic-valve control circuitry 40, and the conductor 38A may pass from inside to outside frame 30, typically through skirt 49.
  • Coupling one of the one or more electrodes 34 to the inner surface of frame 30 may expose the electrode to blood of the subject upon implantation of the assembled prosthetic aortic valve 20.
  • Coupling cathode 54 to the external surface of frame 30 may dispose the cathode against tissue, such as tissue of the annulus that is near the bundle of His, upon implantation of the assembled prosthetic aortic valve 20, such as described herein.
  • the components of electronics component 66 may be stitched to frame 30 and/or skirt 49.
  • prosthetic-valve coil 36 is electrically isolated from frame 30, such as by isolation material (e.g., a sheet of material or a coating) disposed between prosthetic-valve coil 36 and frame 30.
  • isolation material e.g., a sheet of material or a coating
  • the isolation material may comprise a non-conductive polymer.
  • the above-mentioned assembly of prosthetic aortic valve 20 is typically performed in a manufacturing facility, and thereafter the assembled prosthetic aortic valve 20 is packaged and shipped to a healthcare facility for implantation.
  • the method of assembling prosthetic aortic valve 20 is thus non-surgical.
  • Fig. 3 is a schematic illustration of a prosthetic aortic valve 120, in accordance with an application of the present invention.
  • Prosthetic aortic valve 120 is shown in Fig. 3 in an expanded configuration, which is similar to the expanded fully-deployed configuration of prosthetic aortic valve 20 described hereinbelow with reference to Fig. 4C, except that in Fig. 3 expansion of prosthetic aortic valve 120 is not limited by anatomy of a patient.
  • prosthetic aortic valve 120 is identical to prosthetic aortic valve 20 described herein with reference to Figs. 1A-B and 2, and like reference numerals refer to like parts.
  • Prosthetic aortic valve 120 may be assembled as described hereinabove with reference to Fig. 2 for prosthetic aortic valve 20, mutatis mutandis.
  • delivery-system control circuitry 80 is configured to drive the one or more electrodes 34 to apply the rapid ventricular pacing; in this configuration, prosthetic-aortic-valve control circuitry 40, if even provided, is generally passive, i.e., delivery-system control circuitry 80 sets the parameters of the pacing signal.
  • Prosthetic aortic valve 120 shown in Fig. 3, is one implementation of this configuration; unlike the configuration of prosthetic aortic valve 20 illustrated in Figs. 1A-B, prosthetic aortic valve 120 does not comprise prosthetic-aortic-valve control circuitry 40.
  • a valve prosthesis system comprises (a) prosthetic aortic valve 120 and (b) a non-implantable unit, such as delivery system 70, described hereinbelow with reference to Figs. 4A-C, or external unit 100, described hereinbelow with reference to Fig. 4C.
  • Non-implantable control circuitry (such as delivery-system control circuitry 80 or external-unit control circuitry 104 of external unit 100, as appropriate) is configured to drive cathode 54 and anode 57 to apply a pacing signal and to set parameters of the pacing signal (e.g., to be a standard, chronic pacing signal, or a rapid ventricular pacing signal), by wirelessly transferring energy from an energy-transmission coil (such as delivery-system coil 74 or external-unit coil 102, described hereinbelow with reference to Fig. 4C, as appropriate) to prosthetic-valve coil 36 by inductive coupling.
  • the applied pacing is typically bipolar.
  • valve prosthesis system comprises two non-implantable units: (1) delivery system 70, described hereinbelow with reference to Figs. 4A-C, and (2) external unit 100, described hereinbelow with reference to Fig. 4C, which comprise respective control circuitry and energy-transmission coils.
  • Delivery-system control circuitry 80 is configured to drive delivery-system coil 74 to drive cathode 54 and anode 57 to apply the pacing signal and to set the parameters of the pacing signal, by wirelessly transferring energy, by inductive coupling, to prosthetic-valve coil 36 when prosthetic aortic valve 120 is in the partially-deployed configuration, such as described hereinbelow with reference to Fig. 4B.
  • External-unit control circuitry 104 is configured to drive external-unit coil 102, described hereinbelow with reference to Fig. 4C, to drive cathode 54 and anode 57 to apply the pacing signal and to set the parameters of the pacing signal, by wirelessly transferring energy, by inductive coupling, to prosthetic-valve coil 36 when prosthetic aortic valve 120 is in the expanded fully -deployed configuration, such as described hereinbelow with reference to Fig. 4C.
  • respective ends of prosthetic-valve coil 36 are in the non-wireless electrical communication with cathode 54 and anode 57.
  • respective non-electrically-insulated end portions of prosthetic-valve coil 36 define cathode 54 and anode 57.
  • prosthetic aortic valve 120 typically does not comprise elongate insulated electrical conductors 38. Instead, respective insulated end portions of prosthetic-valve coil 36 bend away from prosthetic-valve coil 36 along the paths of elongate insulated electrical conductors 38 shown in Fig. 3, such that the respective non-electrically-insulated end portions of prosthetic-valve coil 36 are located at the locations at which cathode 54 and anode 57 are shown in Fig. 3, respectively.
  • the non-implantable control circuitry is configured to drive cathode 54 and anode 57 to set parameters of the pacing signal.
  • the non implantable control circuitry may be configured to set an amplitude of the pacing signal by modulating an amplitude of the energy wirelessly transferred from the energy- transmission coil to prosthetic-valve coil 36.
  • the non-implantable control circuitry may be configured to drive cathode 54 and anode 57 to (a) begin application of each pulse of the pacing signal by beginning wirelessly transferring energy from the energy-transmission coil to prosthetic-valve coil 36, and (b) conclude the application of each pulse of the pacing signal by ceasing wirelessly transferring energy from the energy-transmission coil to prosthetic-valve coil 36.
  • FIGS. 4A-C are schematic illustrations of a valve prosthesis system 68 and a method of using the system, in accordance with respective applications of the present invention.
  • FIGs. 4A-C are schematic illustrations of a valve prosthesis system 68 and a method of using the system, in accordance with respective applications of the present invention.
  • the rotational orientation of the prosthetic aortic valve is shown schematically in Figs. 4A-C, in order to illustrate the components of the prosthetic aortic valve; as described below, in actual use, the prosthetic aortic valve is typically rotationally oriented such that cathode 54 is positioned adjacent to cardiac tissue near the bundle of His.
  • Valve prosthesis system 68 comprises prosthetic aortic valve 20 or prosthetic aortic valve 120 and a delivery system 70.
  • Delivery system 70 comprises:
  • a delivery-system coil 74 which is coupled to delivery tube 72 at a distal site 76 of delivery tube 72; for example, a distal-most portion 77 of delivery-system coil 74 may be disposed within 10 mm of a distal end 82 of delivery tube 72;
  • wires 78 which pass along delivery tube 72, e.g., attached to an outer or inner surface of delivery tube 72, or embedded in the wall of delivery tube 72;
  • delivery-system control circuitry 80 which is in electrical communication with delivery-system coil 74 via the one or more wires 78.
  • Delivery-system control circuitry 80 is configured to drive delivery-system coil 74 to wirelessly transfer energy, by inductive coupling, to prosthetic-valve coil 36 at least when prosthetic aortic valve 120 is in the partially-deployed configuration described hereinbelow with reference to Fig. 4B.
  • prosthetic aortic valve 120 is removably disposable in delivery tube 72 in a compressed delivery configuration.
  • delivery tube 72 is advanced through vasculature of a patient, until distal end 82 of delivery tube 72 is disposed in an ascending aorta 84 of the patient, while prosthetic aortic valve 120 is removably disposed in delivery tube 72 in the compressed delivery configuration.
  • prosthetic aortic valve 120 is also configured to assume a partially-expanded partially-deployed configuration upon being partially released from distal end 82 of delivery tube 72 such that (a) at least one of the one or more electrodes 34 is positioned outside delivery tube 72, such as cathode 54, in the vicinity of (e.g., touching) target tissue, such as the natural aortic valve annulus, and (b) prosthetic-valve coil 36 is compressed within delivery tube 72.
  • delivery-system coil 74 surrounds compressed prosthetic-valve coil 36, which provides high transmission efficiency even though prosthetic-valve coil 36 is still compressed.
  • delivery- system control circuitry 80 is activated to drive delivery-system coil 74 to wirelessly transfer energy, by inductive coupling, to prosthetic-valve coil 36.
  • transmission of power from an external coil to compressed prosthetic-valve coil 36 would be quite inefficient because of the greater distance between the transmitting and receiving coils and the compression of prosthetic-valve coil 36.
  • valve prosthesis system 68 comprises prosthetic aortic valve 20, described hereinabove with reference to Figs. 1A-B and 2
  • prosthetic- aortic-valve control circuitry 40 is configured to drive the one or more electrodes 34 to apply rapid ventricular pacing. Such pacing may temporarily reduce left ventricular output, in order to enable more accurate placement of prosthetic aortic valve 20.
  • delivery-system control circuitry 80 is configured to drive the one or more electrodes 34 to apply the rapid ventricular pacing; in this configuration, prosthetic-aortic-valve control circuitry 40, if even provided (as in prosthetic aortic valve 20), is generally passive, or prosthetic-aortic- valve control circuitry 40 is not provided (as in prosthetic aortic valve 120), i.e., delivery- system control circuitry 80 sets the parameters of the pacing signal.
  • prosthetic aortic valve 20 or 120 is not used for applying rapid ventricular pacing, and may instead be used for applying pacing post-implantation, such as described below, and/or for post-implantation sensing, such as described below.
  • the one or more electrodes 34 comprise cathode 54 that is coupled to upstream inflow portion 42 of frame 30.
  • cathode 54 is positioned adjacent to cardiac tissue near the bundle of His, in order to pace the heart by stimulating the cardiac tissue with cathodic current.
  • the one or more electrodes further comprise an anode 57, which may be used for bipolar sensing and/or pacing, as known in the art.
  • cathode 54 and anode 57 are disposed on frame 30 such that there is at least 15 mm between the cathode and the anode, when prosthetic aortic valve 120 is in the expanded fully-deployed configuration described hereinbelow with reference to Fig. 4C (the 15 mm is measured along central longitudinal axis 55 of frame 30 when in the expanded fully-deployed configuration).
  • prosthetic aortic valve 120 is also configured to assume an expanded fully-deployed configuration upon being fully released from distal end 82 of delivery tube 72.
  • delivery-system control circuitry 80 is configured to cease driving delivery-system coil 74 to wirelessly transfer the energy when prosthetic aortic valve 120 assumes the expanded fully-deployed configuration upon being fully released from distal end 82 of delivery tube 72.
  • valve prosthesis system 68 further comprises an external unit 100, which comprises (a) an external-unit coil 102, and (b) external-unit control circuitry 104, which is configured to drive external-unit coil 102 to wirelessly transfer energy, by inductive coupling, to prosthetic-valve coil 36 when prosthetic aortic valve 120 is in the expanded fully-deployed configuration.
  • external-unit control circuitry 104 is activated to drive external-unit coil 102 to wirelessly transfer energy, by inductive coupling, to prosthetic-valve coil 36 when prosthetic aortic valve 120 is in the expanded fully -deployed configuration.
  • external-unit coil 102 is incorporated into a collar configured to be worn around the patient's neck or placed on the patient's chest, such as described in PCT Publication WO 2016/157183 to Dagan et al., which is incorporated herein by reference, and/or incorporated into a band configured to be worn around the patient's chest or a necklace configured to be worn around the patient's neck.
  • This positioning of external-unit coil 102 provides high transmission efficiency, because the respective axes of external-unit coil 102 and prosthetic-valve coil 36 are generally aligned.
  • external unit 100 is incorporated into a belt or strap configured to be worn around the patient's chest.
  • valve prosthesis system 68 comprises prosthetic aortic valve 20, described hereinabove with reference to Figs. 1A-B and 2
  • prosthetic- aortic-valve control circuitry 40 is configured to use the received energy to drive the one or more electrodes 34 to perform pacing post-implantation, e.g., for several months.
  • Such pacing may employ any standard pacing protocol.
  • the pacing is VVI pacing, which is only applied when a QRS complex is not sensed in the ventricle.
  • valve prosthesis system 68 comprises prosthetic aortic valve 120, described hereinabove with reference to Fig.
  • external-unit control circuitry 104 is configured to drive the one or more electrodes 34 to apply the pacing signal; in this configuration, prosthetic-aortic-valve control circuitry 40 is not provided (or if provided, is generally passive), i.e., external-unit control circuitry 104 sets the parameters of the pacing signal.
  • prosthetic-aortic-valve control circuitry 40 is configured to (a) use the one or more electrodes 34 to sense a cardiac signal, and (b) drive prosthetic-valve coil 36 to transmit a wireless signal indicative of the sensed cardiac signal.
  • the cardiac sensing is performed using techniques described in US Patent 9,005,106 to Gross et al., which is incorporated herein by reference.
  • the one or more electrodes 34 are typically not used to apply pacing, any thus need not be configured as a cathode and an anode.
  • Such sensing may enable early discharge of the patient from the hospital after implantation of prosthetic aortic valve 20, before the possible development of left bundle branch block (LBBB). If LBBB develops, as it does in approximately 20- 30% of patients, the LBBB is detected by the sensing, an alert is generated, and the LBBB may be treated as appropriate.
  • LBBB left bundle branch block
  • Fig. 5 is a schematic illustration of an electronic implant 200, in accordance with an application of the present invention.
  • Prosthetic-aortic- valve control circuitry 40 described hereinabove with reference to Figs. 1A-2, may implement features of electronic implant 200.
  • Electronic implant 200 comprises circuitry 210, which comprises electronic components 212, typically mounted on a long and flexible printed circuit board (PCB) 214.
  • Electronic implant 200 further comprises a multi-layer protective coating, which comprises the following layers in the following order:
  • ALD atomic layer deposition
  • second parylene layer 222 deposited (typically, vapor-deposited in a vacuum) on first inner AlOx film layer 220; second parylene layer 222 provides chemical protection for circuitry 210;
  • third layer 224 disposed (typically cast onto) on second parylene layer 222, the third layer, for example, comprising a polymer, such as a polymer selected from the group consisting of: silicone and PTFE; third layer 224 typically has a thickness of between 100 and 200 microns, and is configured to provide mechanical protection for circuitry 210; and
  • fourth outer parylene layer 226 deposited (typically, vapor-deposited in a vacuum) on third layer 224; fourth outer parylene layer 226 provides chemical protection for circuitry 210 and third layer 224.
  • Electronic implant 200 and the layers are drawn highly schematically in Fig. 5, and are not drawn to scale; in particular, the layers are actually much thinner than shown, and the relative thicknesses are different from those shown.
  • circuitry 210 is not encased in a case, but is only coated with layers, as described above.
  • a "case” is an enclosure, typically comprising glass and/or metal, that has a structure before circuitry is disposed therein; by contrast, a coating takes the shape of the circuitry to which the coating is applied.
  • encasement in a case is standard in the field of implantable circuitry. The lack of such a case allows electronic implant 200 to be thin and flexible, with the tradeoff of shorter lifespan. For prosthetic- aortic-valve control circuitry 40, the shorter lifespan is generally not an issue, because prosthetic-aortic-valve control circuitry 40 is typically only used for several months.
  • prosthetic-aortic-valve control circuitry 40 implements features of electronic implant 200
  • the one or more electrodes 34 are masked during application of the coatings.
  • prosthetic-aortic-valve control circuitry 40, the one or more elongate insulated electrical conductors 38 (e.g., wires), and prosthetic-valve coil 36 are all coated in the same coating procedure.
  • prosthetic aortic valve 20 may be alternatively used, mutatis mutandis , for non-aortic prosthetic valves, such as prosthetic mitral or tricuspid valves.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Prostheses (AREA)
  • Electrotherapy Devices (AREA)

Abstract

L'invention concerne un système de prothèse de valvule (68) qui comprend une valvule aortique prothétique (120) et une unité non implantable (70, 100). La valvule aortique prothétique (120) comprend une pluralité de feuillets prothétiques (32) ; un cadre (30) ; une cathode (54) et une anode (57) ; et une bobine de valvule prothétique (36), qui est en communication électrique non sans fil avec la cathode (54) et l'anode (57). L'unité non implantable (70, 100) comprend une bobine de transmission d'énergie (74, 102) ; et un circuit de commande non implantable (70, 104), qui est conçu pour amener la cathode (54) et l'anode (57) à appliquer un signal de stimulation et pour : régler des paramètres du signal de stimulation, par transfert sans fil d'énergie provenant de la bobine de transmission d'énergie (74, 102) à la bobine de valvule prothétique (36) par couplage inductif ; commencer l'application de chaque impulsion du signal de stimulation en commençant par le transfert sans fil de l'énergie de la bobine de transmission d'énergie à la bobine de valvule prothétique ; et conclure l'application de chaque impulsion du signal de stimulation par l'arrêt du transfert sans fil de l'énergie de la bobine de transmission d'énergie à la bobine de valvule prothétique. L'invention décrit également d'autres modes de réalisation.
PCT/IL2021/050016 2018-01-08 2021-01-06 Systèmes de stimulation de valvule aortique prothétique WO2021140507A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202180018317.6A CN115297806A (zh) 2020-01-06 2021-01-06 假体主动脉瓣膜起搏系统
US17/328,588 US11291844B2 (en) 2018-01-08 2021-05-24 Prosthetic aortic valve pacing system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/734,798 US10835750B2 (en) 2018-01-08 2020-01-06 Prosthetic aortic valve pacing system
US16/734,798 2020-01-06

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US17/142,729 Continuation-In-Part US11065451B1 (en) 2018-01-08 2021-01-06 Prosthetic aortic valve pacing systems

Related Child Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2021/050017 Continuation-In-Part WO2021224904A1 (fr) 2018-01-08 2021-01-06 Systèmes de stimulation de valvule aortique prothétique

Publications (3)

Publication Number Publication Date
WO2021140507A2 true WO2021140507A2 (fr) 2021-07-15
WO2021140507A3 WO2021140507A3 (fr) 2021-10-07
WO2021140507A9 WO2021140507A9 (fr) 2021-11-25

Family

ID=76787460

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2021/050016 WO2021140507A2 (fr) 2018-01-08 2021-01-06 Systèmes de stimulation de valvule aortique prothétique

Country Status (2)

Country Link
CN (1) CN115297806A (fr)
WO (1) WO2021140507A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11931255B1 (en) 2023-08-18 2024-03-19 E-Valve Systems Ltd. Prosthetic aortic valve pacing systems
US11975203B1 (en) 2023-08-18 2024-05-07 E-Valve Systems Ltd. Prosthetic aortic valve pacing systems

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1918299B2 (de) * 1969-04-10 1972-04-13 Kraus, Werner, Dipl.-Ing., 8000 München Schiene zur fuehrung und heilung frakturierter knochen
CA2776458C (fr) * 2008-10-10 2022-04-26 Peter Forsell Valve artificielle amelioree
US9526637B2 (en) * 2011-09-09 2016-12-27 Enopace Biomedical Ltd. Wireless endovascular stent-based electrodes
CN108836586B (zh) * 2013-11-06 2021-04-06 伊诺佩斯生医有限公司 无线型血管内基于支架的电极
US10543083B2 (en) * 2018-01-08 2020-01-28 Rainbow Medical Ltd. Prosthetic aortic valve pacing system

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11931255B1 (en) 2023-08-18 2024-03-19 E-Valve Systems Ltd. Prosthetic aortic valve pacing systems
US11975203B1 (en) 2023-08-18 2024-05-07 E-Valve Systems Ltd. Prosthetic aortic valve pacing systems

Also Published As

Publication number Publication date
CN115297806A (zh) 2022-11-04
WO2021140507A3 (fr) 2021-10-07
WO2021140507A9 (fr) 2021-11-25

Similar Documents

Publication Publication Date Title
US10543083B2 (en) Prosthetic aortic valve pacing system
US11013597B2 (en) Prosthetic aortic valve pacing system
US10835750B2 (en) Prosthetic aortic valve pacing system
US11291844B2 (en) Prosthetic aortic valve pacing system
US11065451B1 (en) Prosthetic aortic valve pacing systems
JP7357603B2 (ja) 組織の検知および／または刺激するための血管内装置
EP3288495B1 (fr) Dispositif à débit réduit de stimulateur cardiaque lors d'un remplacement de valvules cardiaques
EP3727578B1 (fr) Dispositif médical implantable pour déploiement vasculaire
EP3727576B1 (fr) Dispositif médical implantable pour déploiement vasculaire
US10124175B2 (en) Delivery system assemblies for implantable medical devices
ES2310593T3 (es) Conjunto para la terapia de valvula mitral.
CN110418661A (zh) 用于无引线心脏装置的固定件
WO2021140507A2 (fr) Systèmes de stimulation de valvule aortique prothétique
US20060241732A1 (en) Catheter system for implanting an intravascular medical device
WO2022149130A1 (fr) Systèmes de stimulation de valve aortique prothétique
WO2021224904A1 (fr) Systèmes de stimulation de valvule aortique prothétique
US10485981B2 (en) Fixation methods for leadless cardiac devices
US20170020669A1 (en) Catheter system for locating and implanting a replacement body part
EP4146063A1 (fr) Systèmes de stimulation de valvule aortique prothétique
CN117062584A (zh) 假体主动脉瓣膜起搏系统
US11975203B1 (en) Prosthetic aortic valve pacing systems
US11931255B1 (en) Prosthetic aortic valve pacing systems
EP3562547B1 (fr) Cathéter d'administration sans fil avec chemin conducteur
EP3544645B1 (fr) Procédés et dispositifs de production de fibres trabéculaires
WO2021058555A1 (fr) Système de maintien d'un implant actif dans un appendice auriculaire d'un coeur et procédés d'implantation d'un implant actif

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21738387

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21738387

Country of ref document: EP

Kind code of ref document: A2